Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 712536, 8 pages
http://dx.doi.org/10.1155/2012/712536
Review Article

The Janus Face of Lipids in Human Breast Cancer: How Polyunsaturated Fatty Acids Affect Tumor Cell Hallmarks

1EA2160, Mer Molécules Santé, Université du Maine, Avenue Olivier Messiaen, 72085 Le Mans, France
2Département de Biologie, UFR Sciences et Techniques, 72085 Le Mans, France
3Département Génie Biologique, IUT de Laval, 53020 Laval, France

Received 27 April 2012; Accepted 6 June 2012

Academic Editor: Claudio Luparello

Copyright © 2012 Benoît Chénais and Vincent Blanckaert. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Holmes and W. C. Willett, “Does diet affect breast cancer risk?” Breast Cancer Research, vol. 6, no. 4, pp. 170–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. J. Kinlen, “Diet and breast cancer,” British Medical Bulletin, vol. 47, no. 2, pp. 462–469, 1991. View at Google Scholar · View at Scopus
  3. V. D. Blanckaert, M. E. Schelling, C. A. Elstad, and G. G. Meadows, “Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma,” Cancer Research, vol. 53, no. 17, pp. 4075–4081, 1993. View at Google Scholar · View at Scopus
  4. P. Greenwald, “Clinical trials of breast and prostate cancer prevention,” Journal of Nutrition, vol. 131, no. 1, pp. 176S–178S, 2001. View at Google Scholar · View at Scopus
  5. E. A. Molokhia and A. Perkins, “Preventing Cancer,” Primary Care, vol. 35, no. 4, pp. 609–623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. M. Berquin, I. J. Edwards, and Y. Q. Chen, “Multi-targeted therapy of cancer by omega-3 fatty acids,” Cancer Letters, vol. 269, no. 2, pp. 363–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. D. Hursting, M. Thornquist, and M. M. Henderson, “Types of dietary fat and the incidence of cancer at five sites,” Preventive Medicine, vol. 19, no. 3, pp. 242–253, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Kaizer, N. F. Boyd, V. Kriukov, and D. Tritchler, “Fish consumption and breast cancer risk: an ecological study,” Nutrition and Cancer, vol. 12, no. 1, pp. 61–68, 1989. View at Google Scholar · View at Scopus
  9. S. Sasaki, M. Horacsek, and H. Kesteloot, “An ecological study of the relationship between dietary fat intake and breast cancer mortality,” Preventive Medicine, vol. 22, no. 2, pp. 187–202, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Holmes, S. Liu, S. E. Hankinson, G. A. Colditz, D. J. Hunter, and W. C. Willett, “Dietary carbohydrates, fiber, and breast cancer risk,” American Journal of Epidemiology, vol. 159, no. 8, pp. 732–739, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. MacLean, S. J. Newberry, W. A. Mojica et al., “Effects of omega-3 fatty acids on cancer risk: a systematic review,” The Journal of the American Medical Association, vol. 295, no. 4, pp. 403–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. T. Chlebowski, G. L. Blackburn, C. A. Thomson et al., “Dietary fat reduction and breast cancer outcome: interim efficacy results from the women's intervention nutrition study,” Journal of the National Cancer Institute, vol. 98, no. 24, pp. 1767–1776, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Connolly, E. M. Gilhooly, and D. P. Rose, “Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice,” Nutrition and Cancer, vol. 35, no. 1, pp. 44–49, 1999. View at Google Scholar · View at Scopus
  14. M. Noguchi, T. Taniya, T. Kumaki et al., “Dietary fat and breast cancer: a controversial issue,” Breast Cancer, vol. 4, no. 2, pp. 67–75, 1997. View at Google Scholar
  15. D. P. Rose and J. M. Connolly, “Omega-3 fatty acids as cancer chemopreventive agents,” Pharmacology and Therapeutics, vol. 83, no. 3, pp. 217–244, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Wu, K. A. Harvey, N. Ruzmetov et al., “Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway,” International Journal of Cancer, vol. 117, no. 3, pp. 340–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Chajes, W. Sattler, A. Stranzl, and G. M. Kostner, “Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E,” Breast Cancer Research and Treatment, vol. 34, no. 3, pp. 199–212, 1995. View at Google Scholar · View at Scopus
  18. S. I. Grammatikos, P. V. Subbaiah, T. A. Victor, and W. M. Miller, “n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines,” British Journal of Cancer, vol. 70, no. 2, pp. 219–227, 1994. View at Google Scholar · View at Scopus
  19. P. D. Schley, H. B. Jijon, L. E. Robinson, and C. J. Field, “Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells,” Breast Cancer Research and Treatment, vol. 92, no. 2, pp. 187–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Barascu, P. Besson, O. Le Floch, P. Bougnoux, and M. L. Jourdan, “CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 2, pp. 196–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Blanckaert, L. Ulmann, V. Mimouni, J. Antol, L. Brancquart, and B. Chénais, “Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231,” International Journal of Oncology, vol. 36, no. 3, pp. 737–742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Chamras, A. Ardashian, D. Heber, and J. A. Glaspy, “Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation,” Journal of Nutritional Biochemistry, vol. 13, no. 12, pp. 711–716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Corsetto, G. Montorfano, S. Zava, I. E. Jovenitti, A. Cremona, and A. M. Rizzo, “Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane,” Lipids in Health and Disease, vol. 10, article 73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Judé, S. Roger, E. Martel et al., “Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers,” Progress in Biophysics and Molecular Biology, vol. 90, no. 1–3, pp. 299–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Santen, R. X. Song, R. McPherson et al., “The role of mitogen-activated protein (MAP) kinase in breast cancer,” Journal of Steroid Biochemistry and Molecular Biology, vol. 80, no. 2, pp. 239–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. McCubrey, L. S. Steelman, W. H. Chappell et al., “Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance,” Biochimica et Biophysica Acta, vol. 1773, no. 8, pp. 1263–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Sun, I. M. Berquin, R. T. Owens, J. T. O'Flaherty, and I. J. Edwards, “Peroxisome proliferator-activated receptor γ-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells,” Cancer Research, vol. 68, no. 8, pp. 2912–2919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Sun, Y. Hu, Z. Gu, R. T. Owens, Y. Q. Chen, and I. J. Edwards, “Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway,” Carcinogenesis, vol. 32, no. 10, pp. 1518–1524, 2011. View at Google Scholar
  29. G. Calviello, P. Palozza, P. Franceschelli, and G. M. Bartoli, “Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues,” Lipids, vol. 32, no. 10, pp. 1075–1083, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Hammamieh, D. Sumaida, X. Y. Zhang, R. Das, and M. Jett, “Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism,” BMC Cancer, vol. 7, article 138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K. S. Kang, P. Wang, N. Yamabe, M. Fukui, T. Jay, and B. T. Zhu, “Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation,” PLoS ONE, vol. 5, no. 4, Article ID e10296, 2010. View at Google Scholar · View at Scopus
  32. K. D. Kikawa, J. S. Herrick, R. E. Tateo, M. Mouradian, J. S. Tay, and R. S. Pardini, “Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid,” Nutrition and Cancer, vol. 62, no. 8, pp. 1017–1024, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Leonardi, L. Attorri, R. Di Benedetto et al., “Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells,” Free Radical Research, vol. 39, no. 8, pp. 865–874, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Lindskog, H. Gleissman, F. Ponthan, J. Castro, P. Kogner, and J. I. Johnsen, “Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress,” International Journal of Cancer, vol. 118, no. 10, pp. 2584–2593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Merendino, B. Loppi, M. D'Aquino et al., “Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation,” Nutrition and Cancer, vol. 52, no. 2, pp. 225–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. C. L. L. Saw, Y. Huang, and A. N. Kong, “Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid,” Biochemical Pharmacology, vol. 79, no. 3, pp. 421–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Vibet, C. Goupille, P. Bougnoux, J. P. Steghens, J. Goré, and K. Mahéo, “Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1483–1491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Siddiqui, K. Harvey, and W. Stillwell, “Anticancer properties of oxidation products of docosahexaenoic acid,” Chemistry and Physics of Lipids, vol. 153, no. 1, pp. 47–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Sun, Y. Hu, Z. Gu et al., “Endogenous synthesis of n-3 polyunsaturated fatty acids in Fat-1 mice is associated with increased mammary gland and liver syndecan-1,” PLoS ONE, vol. 6, no. 5, Article ID e20502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. R. S. Chapkin, D. N. Mcmurray, L. A. Davidson, B. S. Patil, Y. Y. Fan, and J. R. Lupton, “Bioactive dietary long-chain fatty acids: emerging mechanisms of action,” British Journal of Nutrition, vol. 100, no. 6, pp. 1152–1157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Aliche-Djoudi, N. Podechard, M. Chevanne et al., “Physical and chemical modulation of lipid rafts by a dietary n-3 polyunsaturated fatty acid increases ethanol-induced oxidative stress,” Free Radical Biology and Medicine, vol. 51, no. 11, pp. 2018–2030, 2011. View at Publisher · View at Google Scholar
  42. P. C. Calder, “Fatty acids and inflammation: the cutting edge between food and pharma,” European Journal of Pharmacology, vol. 668, supplement 1, pp. S50–S58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. P. A. Corsetto, A. Cremona, G. Montorfano et al., “Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation,” Cell Biochemistry and Biophysics. In press. View at Publisher · View at Google Scholar
  44. S. R. Shaikh, D. S. LoCascio, S. P. Soni, S. R. Wassall, and W. Stillwell, “Oleic- and docosahexaenoic acid-containing phosphatidylethanolamines differentially phase separate from sphingomyelin,” Biochimica et Biophysica Acta, vol. 1788, no. 11, pp. 2421–2426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Ye, L. Tan, J. Ma, Q. Shi, and J. Li, “Polyunsaturated docosahexaenoic acid suppresses oxidative stress induced endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 83, no. 1, pp. 37–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. R. Wassall and W. Stillwell, “Docosahexaenoic acid domains: the ultimate non-raft membrane domain,” Chemistry and Physics of Lipids, vol. 153, no. 1, pp. 57–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. R. Wassall and W. Stillwell, “Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes,” Biochimica et Biophysica Acta, vol. 1788, no. 1, pp. 24–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. R. A. Siddiqui, K. A. Harvey, G. P. Zaloga, and W. Stillwell, “Modulation of lipid rafts by omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support,” Nutrition in Clinical Practice, vol. 22, no. 1, pp. 74–88, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. Li, Q. Zhang, M. Wang et al., “Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae,” Archives of Biochemistry and Biophysics, vol. 466, no. 2, pp. 250–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. Q. Li, Q. Zhang, M. Wang, S. Zhao, G. Xu, and J. Li, “n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines,” Molecular Immunology, vol. 45, no. 5, pp. 1356–1365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. D. Altenburg and R. A. Siddiqui, “Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells,” Molecular Cancer Research, vol. 7, no. 7, pp. 1013–1020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. P. D. Schley, D. N. Brindley, and C. J. Field, “(n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells,” Journal of Nutrition, vol. 137, no. 3, pp. 548–553, 2007. View at Google Scholar · View at Scopus
  53. E. Im and J. D. Martinez, “Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells,” Journal of Nutrition, vol. 134, no. 2, pp. 483–486, 2004. View at Google Scholar · View at Scopus
  54. L. Qiu, C. Zhou, Y. Sun et al., “Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells,” Oncology Reports, vol. 16, no. 4, pp. 907–913, 2006. View at Google Scholar · View at Scopus
  55. M. S. Squires, E. A. Hudson, L. Howells et al., “Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells,” Biochemical Pharmacology, vol. 65, no. 3, pp. 361–376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Cuadrado, L. F. García-Fernández, L. González et al., “Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK,” The Journal of Biological Chemistry, vol. 278, no. 1, pp. 241–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. K. R. Rogers, K. D. Kikawa, M. Mouradian et al., “Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association,” Carcinogenesis, vol. 31, no. 9, pp. 1523–1530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. T. Dimanche-Boitrel, A. Rebillard, and E. Gulbins, “Ceramide in chemotherapy of tumors,” Recent Patents on Anti-Cancer Drug Discovery, vol. 6, no. 3, pp. 284–293, 2011. View at Google Scholar
  59. H. Furuya, Y. Shimizu, and T. Kawamori, “Sphingolipids in cancer,” Cancer and Metastasis Reviews, vol. 30, no. 3-4, pp. 567–576, 2011. View at Google Scholar
  60. E. Lafont, K. Kitatani, T. Okazaki, and B. Segui, “Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies,” Recent Patents on Anti-Cancer Drug Discovery, vol. 6, no. 3, pp. 324–333, 2011. View at Google Scholar
  61. M. N. Nikolova-Karakashian and K. A. Rozenova, “Ceramide in stress response,” Advances in Experimental Medicine and Biology, vol. 688, pp. 86–108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Raghu, P. K. Sodadasu, R. R. Malla, C. S. Gondi, N. Estes, and J. S. Rao, “Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells,” BMC Cancer, vol. 10, article 647, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Gillet, S. Roger, P. Bougnoux, J. Y. Le Guennec, and P. Besson, “Beneficial effects of omega-3 long-chain fatty acids in breast cancer and cardiovascular diseases: voltage-gated sodium channels as a common feature?” Biochimie, vol. 93, no. 1, pp. 4–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Isbilen, S. P. Fraser, and M. B. A. Djamgoz, “Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 12, pp. 2173–2182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Maguy, T. E. Hebert, and S. Nattel, “Involvement of lipid rafts and caveolae in cardiac ion channel function,” Cardiovascular Research, vol. 69, no. 4, pp. 798–807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Hiller and Q. D. Chu, “CXCR4 and axillary lymph nodes: review of a potential biomarker for breast cancer metastasis,” International Journal of Breast Cancer, vol. 2011, Article ID 420981, 6 pages, 2011. View at Publisher · View at Google Scholar
  67. M. Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, and N. Yamamoto, “Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer,” Biomedicine and Pharmacotherapy, vol. 60, no. 6, pp. 273–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Müller, B. Homey, H. Soto et al., “Involvement of chemokine receptors in breast cancer metastasis,” Nature, vol. 410, no. 6824, pp. 50–56, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. X. Chen, J. A. Beutler, T. G. McCloud et al., “Tannic acid is an inhibitor of CXCL12 (SDF-1α)/CXCR4 with antiangiogenic activity,” Clinical Cancer Research, vol. 9, no. 8, pp. 3115–3123, 2003. View at Google Scholar · View at Scopus
  70. A. Z. Fernandis, A. Prasad, H. Band, R. Klösel, and R. K. Ganju, “Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells,” Oncogene, vol. 23, no. 1, pp. 157–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Kang, G. Watkins, C. Parr, A. Douglas-Jones, R. E. Mansel, and W. G. Jiang, “Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer,” Breast Cancer Research, vol. 7, no. 4, pp. R402–R410, 2005. View at Google Scholar · View at Scopus
  72. V. Chajès, M. Mahon, and G. M. Kostner, “Influence of LDL oxidation on the proliferation of human breast cancer cells,” Free Radical Biology and Medicine, vol. 20, no. 1, pp. 113–120, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Hardy, W. El-Assaad, E. Przybytkowski, E. Joly, M. Prentki, and Y. Langelier, “Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin,” The Journal of Biological Chemistry, vol. 278, no. 34, pp. 31861–31870, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Rotheneder and G. M. Kostner, “Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines,” International Journal of Cancer, vol. 43, no. 5, pp. 875–879, 1989. View at Google Scholar · View at Scopus
  75. C. J. Antalis, T. Arnold, T. Rasool, B. Lee, K. K. Buhman, and R. A. Siddiqui, “High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation,” Breast Cancer Research and Treatment, vol. 122, no. 3, pp. 661–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. R. M. Neve, K. Chin, J. Fridlyand et al., “A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes,” Cancer Cell, vol. 10, no. 6, pp. 515–527, 2006. View at Google Scholar
  77. P. Farmer, H. Bonnefoi, V. Becette et al., “Identification of molecular apocrine breast tumours by microarray analysis,” Oncogene, vol. 24, no. 29, pp. 4660–4671, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. A. L. Richardson, Z. C. Wang, A. de Nicolo et al., “X chromosomal abnormalities in basal-like human breast cancer,” Cancer Cell, vol. 9, no. 2, pp. 121–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. M. J. van de Vijver, Y. D. He, L. J. van'T Veer et al., “A gene-expression signature as a predictor of survival in breast cancer,” The New England Journal of Medicine, vol. 347, no. 25, pp. 1999–2009, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. L. J. van't Veer, H. Dai, M. J. van de Vijver et al., “Gene expression profiling predicts clinical outcome of breast cancer,” Nature, vol. 415, no. 6871, pp. 530–536, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. C. J. Antalis, A. Uchida, K. K. Buhman, and R. A. Siddiqui, “Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification,” Clinical and Experimental Metastasis, vol. 28, no. 8, pp. 733–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. N. W. Chang, C. T. Wu, C. D. R, C. Y. Yeh, and C. Lin, “High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation,” Journal of Nutritional Biochemistry. In press.
  83. E. Hietanen, K. Punnonen, R. Punnonen, and O. Auvinen, “Fatty acid composition of phospholipids and neutral lipids and lipid peroxidation in human breast cancer and lipoma tissue,” Carcinogenesis, vol. 7, no. 12, pp. 1965–1969, 1986. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Maillard, P. Bougnoux, P. Ferrari et al., “n-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in tours, France,” International Journal of Cancer, vol. 98, no. 1, pp. 78–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. D. M. Ray, P. H. Myers, J. T. Painter, M. J. Hoenerhoff, K. Olden, and J. D. Roberts, “Inhibition of transforming growth factor-beta-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis,” British Journal of Cancer. In press. View at Publisher · View at Google Scholar
  86. D. M. Ray, B. A. Rogers, J. A. Sunman, S. K. Akiyama, K. Olden, and J. D. Roberts, “Lysine 63-linked ubiquitination is important for arachidonic acid-induced cellular adhesion and migration,” Biochemistry and Cell Biology, vol. 88, no. 6, pp. 947–956, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Villegas-Comonfort, N. Serna-Marquez, O. Galindo-Hernandez, N. Navarro-Tito, and E. P. Salazar, “Arachidonic acid induces an increase of beta-1,4-galactosyltransferase I expression in MDA-MB-231 breast cancer cells,” Journal of Cellular Biochemistry. In press.
  88. Z. H. Wen, Y. C. Su, P. L. Lai et al., “Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis andangiogenesis,” Oncogene. In press. View at Publisher · View at Google Scholar
  89. P. M. Maloberti, A. B. Duarte, U. D. Orlando et al., “Functional interaction between acyl-coa synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells,” PLoS ONE, vol. 5, no. 11, Article ID e15540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. C. H. Byon, R. W. Hardy, C. Ren et al., “Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4,” Laboratory Investigation, vol. 89, no. 11, pp. 1221–1228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Reyes, I. Reyes, R. Tiwari, and J. Geliebter, “Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D,” Cancer Letters, vol. 209, no. 1, pp. 25–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Espinosa-Neira, J. Mejia-Rangel, P. Cortes-Reynosa, and E. P. Salazar, “Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A,” The International Journal of Biochemistry and Cell Biology, vol. 43, no. 12, pp. 1782–1791, 2011. View at Google Scholar
  93. N. S. Kelley, N. E. Hubbard, and K. L. Erickson, “Conjugated linoleic acid isomers and cancer,” Journal of Nutrition, vol. 137, no. 12, pp. 2599–2607, 2007. View at Google Scholar · View at Scopus
  94. D. L. Amarù and C. J. Field, “Conjugated linoleic acid decreases MCF-7 human breast cancer cell growth and insulin-like growth factor-1 receptor levels,” Lipids, vol. 44, no. 5, pp. 449–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. M. A. Islam, Y. S. Kim, W. J. Jang et al., “A mixture of trans, trans conjugated linoleic acid induces apoptosis in MCF-7 human breast cancer cells with reciporocal expression of Bax and Bcl-2,” Journal of Agricultural and Food Chemistry, vol. 56, no. 14, pp. 5970–5976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. L. S. Wang, Y. W. Huang, S. Liu, P. Yan, and Y. C. Lin, “Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue,” BMC Cancer, vol. 8, article 208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Miglietta, F. Bozzo, C. Bocca et al., “Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway,” Cancer Letters, vol. 234, no. 2, pp. 149–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Bocca, F. Bozzo, S. Cannito, S. Colombatto, and A. Miglietta, “CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways,” Chemico-Biological Interactions, vol. 183, no. 1, pp. 187–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Bocca, F. Bozzo, S. Francica, S. Colombatto, and A. Miglietta, “Involvement of PPARγ and E-cadherin/β-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells,” International Journal of Cancer, vol. 121, no. 2, pp. 248–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. P. S. P. Huot, B. Sarkar, and D. W. L. Ma, “Conjugated linoleic acid alters caveolae phospholipid fatty acid composition and decreases caveolin-1 expression in MCF-7 breast cancer cells,” Nutrition Research, vol. 30, no. 3, pp. 179–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. M. P. Fay and L. S. Freedman, “Meta-analyses of dietary fats and mammary neoplasms in rodent experiments,” Breast Cancer Research and Treatment, vol. 46, no. 2-3, pp. 215–223, 1997. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Ip, “Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals,” American Journal of Clinical Nutrition, vol. 66, no. 6, supplement, pp. 1523S–1529S, 1997. View at Google Scholar · View at Scopus
  103. D. P. Rose, “Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies,” American Journal of Clinical Nutrition, vol. 66, no. 6, supplement, pp. 1513S–1522S, 1997. View at Google Scholar · View at Scopus
  104. M. Wada, C. J. DeLong, Y. H. Hong et al., “Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products,” The Journal of Biological Chemistry, vol. 282, no. 31, pp. 22254–22266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Bagga, K. H. Anders, H. J. Wang, and J. A. Glaspy, “Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer,” Nutrition and Cancer, vol. 42, no. 2, pp. 180–185, 2002. View at Google Scholar · View at Scopus
  106. H. J. Murff, X. O. Shu, H. Li et al., “Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study,” International Journal of Cancer, vol. 128, no. 6, pp. 1434–1441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Gago-Dominguez, J. M. Yuan, C. L. Sun, H. P. Lee, and M. C. Yu, “Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese health study,” British Journal of Cancer, vol. 89, no. 9, pp. 1686–1692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. D. J. Bernard-Gallon, C. Vissac-Sabatier, D. Antoine-Vincent et al., “Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines,” British Journal of Nutrition, vol. 87, no. 4, pp. 281–289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. P. Bougnoux, N. Hajjaji, M. N. Ferrasson, B. Giraudeau, C. Couet, and O. Le Floch, “Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial,” British Journal of Cancer, vol. 101, no. 12, pp. 1978–1985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier, “Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth,” Progress in Lipid Research, vol. 49, no. 1, pp. 76–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. J. D. Altenburg, A. A. Bieberich, C. Terry et al., “A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone,” BMC Cancer, vol. 11, article 149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. R. A. Siddiqui, K. A. Harvey, Z. Xu, E. M. Bammerlin, C. Walker, and J. D. Altenburg, “Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects,” Biofactors, vol. 37, no. 6, pp. 399–412, 2011. View at Publisher · View at Google Scholar